LLY vs SYM · P/E 39, rev $65.18B vs rev $2.25B
Eli Lilly and Company (LLY) versus Symbotic Inc (SYM) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Symbotic Inc (SYM) is a specialty industrial machinery company listed on NASDAQ.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported SYM revenue for 2025-09-27 was $2.25B. Net income was -$91.0M. Revenue was up 298.0% from 2024-09-28 to 2025-09-27. SYM currently screens at market cap $24.25B.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. SYM currently screens at market cap $24.25B.
Not investment advice. Open the LLY and SYM stock pages for the full models.
Not investment advice.